. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Parkinsonism Relat Disord. 2014 Dec 24;21(3):306–309. doi: 10.1016/j.parkreldis.2014.12.010

Table 1.

Clinical-epidemiological data of the ET-control series analyzed.

	Spain[2,3]	Italy	Germany	Taiwan	America	Total
Controls
N	2715	357	299	100	697	4168
Female, N. (%)	1595 (58.8)	153 (42.9)	121 (40.5)	50 (50)	412 (58.9)	2331 (55.9)
Current age, y	73.51	68.18	66.36 (5.45)	64.96	72.87	72.22
Mean (SD)	(10.35)	(7.69)	[57–85]	(10.55)	(13.24)	(11.32)
[Range]	[30–99]^a	[35–86]		[41–90]	[30–98]	[30–99]
Cases^b
N	456	265	275	100	257	1353
Gender; N. (%)	216 (48.3)	106 (40)	112 (40.7)	50 (50)	137 (53.3)	621 (46.2)
Age at onset, y	49.86	55.49	48.33	54.70	50.66	51.44
Mean (SD)	(20.11)	(15.80)	(20.01)	(17.29)	(19.98)	(19.15)
[Range]	[4–89]	[7–80]	[4–83]	[7–86]	[5–88]	[4–89]
Current age, y	66.11	67.44	67.94	64.96	73.42	68.43
Mean (SD)	(15.97)	(10.46)	(14.06)	(12.56)	(11.73)	(13.82)
[Range]	[16–98]	[25–95]	[21–96]	[20–87]	[35–98]	[16–98]

N: number of individuals; SD: standard deviation.

Range data only available from in-house genotyping data [3].

ET cases have been defined according to the current diagnostic criteria published by Deuschl et al. [12].